NMTC NeuroOne Medical
- 0.9541
- +0.0024+0.25%
- 0.9541
- 0.00000.00%
NeuroOne Medical News
NeuroOne Medical(NMTC.US) Officer Sells US$1,917.56 in Common Stock
$NeuroOne Medical(NMTC.US)$ Officer Christianson Mark sold 2,189 shares of common stock on Jun 6, 2024 at an average price of $0.876 for a total value of $1,917.56.Source: Announcement What is stateme
NeuroOne Medical(NMTC.US) Officer Sells US$22,662.72 in Common Stock
$NeuroOne Medical(NMTC.US)$ Officer Christianson Mark sold 25,800 shares of common stock on Jun 5, 2024 at an average price of $0.8784 for a total value of $22,662.72.Source: Announcement What is stat
Express News | NeuroOne Medical Technologies Corp Files For Mixed Shelf Offering Of Up To $150M
Express News | Neuroone Medical Technologies Corp Files for Mixed Shelf of up to $150 Mln – SEC Filing
Earnings Call Summary | NeuroOne Medical(NMTC.US) Q2 2024 Earnings Conference
The following is a summary of the NeuroOne Medical Technologies Corporation (NMTC) Q2 2024 Earnings Call Transcript:Financial Performance:NeuroOne reported a significant growth in Q2 product revenue o
NeuroOne Medical Technologies Corporation (NMTC) Q2 2024 Earnings Call Transcript
NeuroOne Medical Technologies Corporation (NMTC) Q2 2024 Earnings Call Transcript
NeuroOne Medical | 10-Q: Quarterly report
Express News | NeuroOne Medical Tech Q2 2024 GAAP EPS $(0.11) Misses $(0.08) Estimate, Sales $1.38M Up From $466.18K YoY
Express News | Neuroone® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
Express News | Neuroone Medical Technologies Q2 Net Income USD -2.9 Million
Express News | Neuroone Medical Technologies Q2 Operating Expenses USD 3.3 Million
NeuroOne Medical Tech 2Q Rev $1.38M >NMTC
NeuroOne Medical Tech 2Q Rev $1.38M >NMTC
Express News | Neuroone® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14
NeuroOne CEO Dave Rosa Featured on Bloomberg Technology
EDEN PRAIRIE, Minn., April 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and
NeuroOne Announces First Implant of OneRF Ablation Electrodes
First to market FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control EDEN PRAIRIE, Minn., April 09, 2024
NeuroOne CEO Dave Rosa Featured on Fox Business Network's Varney & Co.
EDEN PRAIRIE, Minn., April 04, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surg
NeuroOne Initiates Limited Commercial Launch of OneRF Ablation System
First to market FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control Limited commercial launch
NeuroOne Medical Advances With Key Shareholder Decisions
12 Health Care Stocks Moving In Monday's Intraday Session
GainersRegencell Bioscience (NASDAQ:RGC) shares rose 130.9% to $10.39 during Monday's regular session. The company's market cap stands at $135.2 million. TC BioPharm (Holdings) (NASDAQ:TCBP) shares in
NeuroOne to Participate in the 36th Annual Roth Conference
EDEN PRAIRIE, Minn., March 08, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical
Analysis
Price Target
No Data
